Medical News: ASCO: Trabectedin Useful in Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
Links shared publicly online about this topic.
- 1,109total visits
Medical News: ASCO: Trabectedin Useful in Recurrent Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
CHICAGO -- Trabectedin may have a role in the treatment of recurrent ovarian cancer while sparing patients for a time from platinum-based regimens, according to several studies presented here.
View full resource at medpagetoday.com
Tags: Cancer, Ovarian Cancer, Women's Health, News, Medical
Most Recently Shared on June 8, 2010 at 5:51 pm By:
ASCO: Trabectedin Useful in Recurrent Ovarian Cancer http://bit.ly/cdzGwZ
Medical News: ASCO: Abagovomab No Help in Ovarian Cancer - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Results from a study using the experimental monoclonal antibody drug abagovomab to protect women with advanced ovarian cancer from recurrence have been disappointing, researchers reported h” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:23 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: ASCO: Abagovomab No Help in Ovarian Cancer - http://t.co/ktG6ubc from @medpagetoday #health #medicine
Advertisement
